About Ticagrelor
            
            Class: | Antiplatelet agent, P2Y12 inhibitor  
Use: | Prevention of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) and in patients with a history of myocardial infarction (MI)  
Adult dose: | Initial dose: 180 mg orally once; Maintenance dose: 90 mg orally twice daily  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Common side effects include dyspnea, bleeding, headache, dizziness, and nausea  
Contraindications: | 
         
        
            
                
                
                    
                        Drug Class
                    
                    Antiplatelet agent, P2Y12 inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Prevention of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) and in patients with a history of myocardial infarction (MI)
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: AstraZeneca AB, SWEDEN
                    
                    
                    Package Size
                    56's (14's Blister x 4)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 438.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 180 mg orally once; Maintenance dose: 90 mg orally twice daily
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include dyspnea, bleeding, headache, dizziness, and nausea
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Active bleeding (e.g., intracranial hemorrhage, gastrointestinal bleeding), history of intracranial hemorrhage, severe hepatic impairment, hypersensitivity to ticagrelor or any component of the formulation
         
        
        
            
                Important Warnings
            
            Increased risk of bleeding; use caution in patients with a history of bleeding disorders; avoid use with strong CYP3A4 inducers and inhibitors; monitor for signs of bleeding and adjust therapy as necessary
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.